Clinical Trial Information Request for Protocol 22-116 Title A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 Study comparing the effect of abelacimab relaTive to apixaban on venous thromboEmbolism (VTE) recurrence and bleeding in patients with canceR associated VTE (ASTER) PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone